Authors:
Gupta, GK
Cole, CH
Abbasi, S
Demissie, S
Njinimbam, C
Nielsen, HC
Colton, T
Frantz, ID
Citation: Gk. Gupta et al., Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL-8 and IL-1ra in ventilated preterm infants at risk forbronchopulmonary dysplasia, PEDIAT PULM, 30(4), 2000, pp. 275-281
Citation: Ch. Cole, Postnatal glucocorticosteroid therapy for treatment and prevention of neonatal chronic lung disease, EXPERT OP I, 9(1), 2000, pp. 53-67
Authors:
Dolovich, MB
MacIntyre, NR
Anderson, PJ
Camargo, CA
Chew, N
Cole, CH
Dhand, R
Fink, JB
Gross, NJ
Hess, DR
Hickey, AJ
Kim, CS
Martonen, TB
Pierson, DJ
Rubin, BK
Smaldone, GC
Citation: Mb. Dolovich et al., Consensus statement: Aerosols and delivery devices, J AEROSOL M, 13(3), 2000, pp. 291-300
Authors:
Arias-Camison, JM
Lau, J
Cole, CH
Frantz, ID
Citation: Jm. Arias-camison et al., Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants, PEDIAT PULM, 28(3), 1999, pp. 167-174
Citation: Ch. Cole et Mln. Willoughby, The total care unit for pediatric hematology and oncology, Princess Margaret Hospital for Children, Perth, Australia, PED HEM ONC, 16(4), 1999, pp. 285-289